📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries. (2022)

First Author: Humbert MV

Attributed to: RAPID point-of-care infection detection and antibiotic-resistance TESTing enabled with laser-patterned microfluidic devices (RAPID-TEST) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2021.08.049

PubMed Identifier: 34606784

Publication URI: http://europepmc.org/abstract/MED/34606784

Type: Journal Article/Review

Volume: 84

Parent Publication: The Journal of infection

Issue: 1

ISSN: 0163-4453